Amyris, Inc. (AMRS) is up 0.39% in the pre-market trading session at the price of $13.00 despite any recent news.
AMRS Reported Second Quarter 2021 Financial Results
On 5th August 2021, AMRS published a financial report for its second quarter ended on 30th June 2021. Total revenue reported for second-quarter 2021 was $52.3 million. It included record underlying and consumer revenue, plus $10 million of proceeds resulting from the strategic Reb M sweetener transaction. Total underlying revenue grew 41% to $42.3 million compared to the same quarter 2020 revenue. It was driven primarily by a 59% gain in consumer sales and a 25% increment in ingredient sales. Second-quarter consumer revenue reached a new record, with Biossance doubling the total revenues. GAAP earnings per share were $0.05 or $0.61 gain, compared to -$0.56 in the same quarter of 2020. Adjusted net loss in this quarter was $49 million or $0.15 per share, improved $9 million or $0.16 per share. Adjusted net loss of $58 million or $0.31 per share was reported for the second quarter of 2020.
Total revenue in the first half of 2020 was $229 million. A gain of 288% from the same period of the previous year. Total revenue included $154 million, resulting from strategic transactions. Net loss was $275 million compared to a net loss of $191 million in the first half of 2020. Adjusted net income this period was $46 million or $0.16 per share. An adjusted net loss of $102 million or $0.60 per share was reported for H1 2020.
CEO John Melo remarked that they had completed another quarter of strategic and operational execution. They improved margins YoY significantly and achieved record underlying revenue driven by record consumer revenue. Their homegrown clean beauty brands, Biossance and Pipette, produced record revenue. Biossance doubled the revenue compared to the prior year this quarter. The performance of these brands is proof of the rapid growing consumer high-performance, affordable, and sustainable clean beauty products. In addition to the reported revenue, they had made outstanding sales of $2.4 million, he added. They made notable efforts and investments in marketing and supply chain in Q2. Moreover, they are working to launching their new brands in Q3. Future brands like Rose Inc., JVN, Terasana, and Olika will add significant new revenue to their consumer portfolio in the second half of 2020, he further remarked.
Amyris Partnered With Naomi Watts
On 22nd July 2021, AMRS declared a partnership with Naomi Watts to establish a new consumer brand. The brand will work on providing science-backed and menopause wellness personal care products. Actress and co-founder of ONDA Beauty, Ms. Watts, has a personal devotion to clean skincare, wellness, and destigmatizing menopause.
There will be over one billion people experiencing menopause in the world by 2025. It will be 12% of the entire world population of eight billion. Various symptoms and conditions of menopause are being experienced by 75% of women. They can lead to a significant reduction in quality of life, increased utilization of medical resources, and an overall loss of productivity. Stigma, lack of open discussion, and small product offering at an affordable price add to the barrier for women. Introducing this new brand furthers Amyris’ growth and market leadership. It will provide clean health, beauty, and wellness to users of each age group and complements Amyris’ family of leading consumer brands.
